U.S. Market Wrap

ONEOK (OKE) Q2 FY2026: Revenue +53%, EPS $1.53, Guidance Raised; Margin -4.9pp

ONEOK Inc. (NYSE: OKE), one of the largest midstream operators in the United States, reported second-quarter 2026 results on August 3, 2026, and filed its 10-Q

02
Eli Lilly Bets $2.88B on Merida Biosciences to Move Beyond Obesity — Three Watch Points for LLY
Eli Lilly's 13th acquisition of 2026 targets Merida Biosciences' antibody-degrading MER511. Three watch points for LLY investors from the $2.88B autoimmune bet.

LineVest Daily

Get this wrap in your inbox every morning.

One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.

Subscribe free

← Friday, September 4, 2026 All coverage →

ONEOK (OKE) Q2 FY2026: Revenue +53%, EPS $1.53, Guidance Raised; Margin -4.9pp

Eli Lilly Bets $2.88B on Merida Biosciences to Move Beyond Obesity — Three Watch Points for LLY

Get this wrap in your inbox every morning.